about
Osteoimmunology: interactions of the bone and immune systemNF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destructionA dynamic real time in vivo and static ex vivo analysis of granulomonocytic cell migration in the collagen-induced arthritis modelNFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism.The efficacy of shikonin on cartilage protection in a mouse model of rheumatoid arthritis.The final pathogenetic steps in focal bone erosions in rheumatoid arthritisThe pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis.Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases.Glucocorticoid-induced leucine zipper (GILZ) antagonizes TNF-α inhibition of mesenchymal stem cell osteogenic differentiation.Osteoclasts are essential for TNF-alpha-mediated joint destruction.THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritisInactivation of DAP12 in PMN inhibits TREM1-mediated activation in rheumatoid arthritisMinireview: nuclear receptor regulation of osteoclast and bone remodeling.B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal diseaseBone density and hyperlipidemia: the T-lymphocyte connection.Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosisCathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation.Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligandRANK, RANKL and osteoprotegerin in arthritic bone loss.Phenotypic characterization of type II collagen-induced arthritis in Wistar rats.IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints.Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts.A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.A potential role of myeloid DAP12-associating lectin (MDL)-1 in the regulation of inflammation in rheumatoid arthritis patients.Regulation of TNF-α with a focus on rheumatoid arthritis.Blockade of co-stimulation in chronic inflammatory diseases.Multicentric reticulohistiocytosis: a critical review.Rocaglamide-A Potentiates Osteoblast Differentiation by Inhibiting NF-κB Signaling.Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling.Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor.Comprehensive profiling analysis of actively resorbing osteoclasts identifies critical signaling pathways regulated by bone substrateTumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.Bone-targeted methotrexate-alendronate conjugate inhibits osteoclastogenesis in vitro and prevents bone loss and inflammation of collagen-induced arthritis in vivo.Tumor necrosis factor-α inhibits chondrogenic differentiation of synovial fibroblasts through p38 mitogen activating protein kinase pathways.TNF-α inhibits SATB2 expression and osteoblast differentiation through NF-κB and MAPK pathways.Lemnalol attenuates mast cell activation and osteoclast activity in a gouty arthritis model.Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis.Minodronic acid influences receptor activator of nuclear factor kappaB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis.Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis.
P2860
Q24655113-DDC9953A-E3F4-42BA-8B25-D97FDF4186FFQ24805487-9C05FA0B-C41B-4F22-8ADF-81E33EA69DFDQ27304648-3AF7F10C-5A2F-4C89-AF3A-E2D059F763ACQ30157499-9A6327B3-C9C2-4F99-80FC-76BB464A8515Q33688124-25396562-72EA-4EEE-87AD-A7273BFF0EEFQ34071304-C0DA67D5-B619-43A2-9B94-F2F22A043AB1Q34122715-EF729F98-12AE-442E-A9FB-333BA33DF858Q34154425-127E22D0-7B5D-4FD5-A8D8-08F9AD6BB76AQ34187108-8ADBE690-E14B-4E30-9479-87DF199F8DA7Q34826003-C9E7FE23-C405-43FE-99EB-A83ED912BFE6Q34895962-520A6B53-BCAD-4E57-A37E-4000E4400756Q35038322-D99C9F1B-A185-4ED6-A22C-CA641B6FBE25Q35054970-932D5798-FECB-4193-A931-D7297E61272FQ35222008-1BB2897F-8E21-4957-88AB-2D28F5532099Q35229853-196E0136-752B-4295-AC6E-3EA49941E05BQ35552836-AC4CFCDF-9E9B-4156-ABA3-533F7B62909EQ35747144-65DEC2CB-A3B9-452C-A9D7-42166DAEC313Q35748007-B2668C5A-7AEF-46F8-9484-F88353FE0A6BQ36078073-11750A0E-518B-42AA-AFCA-BACA7CC5C3FEQ36081326-F81C703A-B501-4AE1-B5D4-19F27B392C33Q36444288-46469FB1-936A-4644-A8DB-2E2708DF6C67Q36907683-36B7548E-47F1-4FB7-9564-729BBDDD7B57Q37109228-91E4D431-C40E-4B29-ABC9-B8B93145AEB3Q37390483-086CCB6A-E2C2-4601-BD50-5FBA8C1105D0Q37500085-77DFC352-96B1-4094-B252-FDB1C0DDBD16Q38102876-F5879A33-E852-49F7-8332-A3429D4EAEF6Q38255765-0DFF743A-2B89-447F-9259-7CE44009BCA0Q38434277-1055A9EA-AA19-4091-AB6F-0C9D0575A115Q38820948-52E1C12B-F832-4355-BD7A-B5345B37E2F9Q38894222-63973379-576B-46E0-BC08-F8C93F4D4873Q40838540-287FDADE-C54A-4674-AC87-51C139A569B8Q41939951-E49D8B89-CF0C-44FD-B919-B30004B03BC3Q43937881-FB4FF753-BD3E-431A-8D9B-D6262D5E8A68Q47199326-B8188A3B-F2DA-4171-9B12-A755F55667DEQ47888590-4DB532DB-E2DE-464F-9D83-33A95C4DF26CQ49621194-196D5252-9E12-4AF1-8B3A-A083403DE81DQ50218797-A6F328CC-29F0-46B1-8905-A7E7C3518FC9Q50874643-CE7D4870-E194-4A89-83D9-8D0B7348BE00Q51750426-F45801CE-5905-4323-81D7-FD500E3772EEQ52894906-375C4131-65F9-4420-8BA3-FE58AF8DA7B9
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pathogenesis of bone erosions in rheumatoid arthritis.
@ast
Pathogenesis of bone erosions in rheumatoid arthritis.
@en
type
label
Pathogenesis of bone erosions in rheumatoid arthritis.
@ast
Pathogenesis of bone erosions in rheumatoid arthritis.
@en
prefLabel
Pathogenesis of bone erosions in rheumatoid arthritis.
@ast
Pathogenesis of bone erosions in rheumatoid arthritis.
@en
P1476
Pathogenesis of bone erosions in rheumatoid arthritis.
@en
P2093
Goldring SR
Gravallese EM
P304
P356
10.1097/00002281-200005000-00006
P577
2000-05-01T00:00:00Z